These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 21281021

  • 1. Insulin resistance and the long-term consequences of polycystic ovary syndrome.
    Bhathena RK.
    J Obstet Gynaecol; 2011; 31(2):105-10. PubMed ID: 21281021
    [Abstract] [Full Text] [Related]

  • 2. Insulin resistance in polycystic ovary syndrome.
    Prelevic GM.
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):193-201. PubMed ID: 9263704
    [Abstract] [Full Text] [Related]

  • 3. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
    Vrbíková J, Hill M, Stárka L, Cibula D, Snajderová M, Sulcová J, Vondra K, Bendlová B.
    Cas Lek Cesk; 2001 Nov 08; 140(22):688-94. PubMed ID: 11789058
    [Abstract] [Full Text] [Related]

  • 4. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E, Jarosz-Chobot P, Deja G.
    Przegl Lek; 2006 Nov 08; 63(4):234-8. PubMed ID: 17080748
    [Abstract] [Full Text] [Related]

  • 5. Insulin resistance and metformin in polycystic ovary syndrome.
    Ben-Haroush A, Yogev Y, Fisch B.
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug 10; 115(2):125-33. PubMed ID: 15262344
    [Abstract] [Full Text] [Related]

  • 6. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C, Cardoza L, Coutiño B, Hidalgo R, Arteaga-Troncoso G, Parra A.
    J Endocrinol; 2005 Jan 10; 184(1):233-9. PubMed ID: 15642799
    [Abstract] [Full Text] [Related]

  • 7. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
    Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Sanchón R, San Millán JL, Escobar-Morreale HF.
    Diabetes Care; 2007 Sep 10; 30(9):2309-13. PubMed ID: 17536071
    [Abstract] [Full Text] [Related]

  • 8. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B, Gambineri A, Pasquali R.
    Minerva Ginecol; 2004 Feb 10; 56(1):41-51. PubMed ID: 14973409
    [Abstract] [Full Text] [Related]

  • 9. Association of metformin and pregnancy in the polycystic ovary syndrome. A report of three cases.
    Seale FG, Robinson RD, Neal GS.
    J Reprod Med; 2000 Jun 10; 45(6):507-10. PubMed ID: 10900588
    [Abstract] [Full Text] [Related]

  • 10. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
    Franks S.
    Clin Endocrinol (Oxf); 2011 Feb 10; 74(2):148-51. PubMed ID: 21121941
    [Abstract] [Full Text] [Related]

  • 11. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF, Nilas L, Nørgaard K, Madsbad S.
    Ugeskr Laeger; 2005 Aug 22; 167(34):3147-51. PubMed ID: 16117910
    [Abstract] [Full Text] [Related]

  • 12. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA, Hernández Marín I, Ayala AR.
    Ginecol Obstet Mex; 2005 Jun 22; 73(6):315-27. PubMed ID: 16309038
    [Abstract] [Full Text] [Related]

  • 13. Current perspectives of insulin resistance and polycystic ovary syndrome.
    Pauli JM, Raja-Khan N, Wu X, Legro RS.
    Diabet Med; 2011 Dec 22; 28(12):1445-54. PubMed ID: 21950959
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ, Hutchison SK, Zoungas S.
    Trends Endocrinol Metab; 2007 Sep 22; 18(7):273-9. PubMed ID: 17698366
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.